Stem Cell Therapies for Cardiac Disease: Which Cell Types Are the Best

Abstract

Stem cell therapy for the treatment of cardiovascular disease is increasingly being researched during the past few decades. Due to the risk of cardiac transplantation surgery and the nature of cardiac cell lines, the regenerative potential of stem cell therapy is being extremely expected. Popular cell lines are discussed in this study, which includes mesenchymal stem cells, bone marrow-derived mononuclear stem cells, embryonic stem cells, hematopoietic stem cells, endothelial progenitor cells, tissue-specific stem cells, umbilical cord blood stem cells, skeletal myoblast and induced pluripotent stem cells. The purpose of this study is to review the current use of various cell types for stem cell therapy in cardiovascular patients, as mentioned above. Additionally, optimal delivery methods of stem cell therapies are also discussed in patients with and without secondary stroke conditions. Literature from the Internet was searched and primary studies with the cell types of interest were carefully examined and included in the study. Although from current literature in the field stem cell therapies have great potential to be used in cardiovascular patients, more extensive research with a greater number is warranted before widespread application in the clinical setting.